Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 20-Nov-24 8:23 AM View:  | Diep Tuan Tu Chief Development Officer | Skye Bioscience, Inc. (SKYE) | 18-Nov-24 | Sale | 19,489 | $4.99 | $97,250.10 | (19%) 101.75K to 82.26K | |
| 19-Nov-24 9:20 PM View: | Dhillon Punit Chief Executive Officer Director | Skye Bioscience, Inc. (SKYE) | 18-Nov-24 | Sale | 82,546 | $4.99 | $411,905.00 | (20%) 421.71K to 339.17K | |
| 19-Nov-24 9:20 PM View: | Dhillon Punit Chief Executive Officer Director | Skye Bioscience, Inc. (SKYE) | 15-Nov-24 | Private Sale | 364 | $5.55 | $2,020.20 | (< 1%) 422.08K to 421.71K | |
| 20-Nov-24 8:23 AM View: | Diep Tuan Tu Chief Development Officer | Skye Bioscience, Inc. (SKYE) | 15-Nov-24 | Private Sale | 85 | $5.55 | $471.75 | (< 1%) 101.83K to 101.75K | |
| 13-Sep-24 6:56 PM View: | Schwab Andrew J. Director 10% Owner | Skye Bioscience, Inc. (SKYE) | 13-Sep-24 | Sale Duplicate | 13,837 | $6.06 | $83,852.20 | (< 1%) 9.93M to 9.91M | |
| 13-Sep-24 6:54 PM View: | 5am Partners Vii, LLC 10% Owner | Skye Bioscience, Inc. (SKYE) | 13-Sep-24 | Sale | 13,837 | $6.06 | $83,852.20 | (< 1%) 9.93M to 9.91M | |
| 13-Sep-24 6:54 PM View: | 5am Partners Vii, LLC 10% Owner | Skye Bioscience, Inc. (SKYE) | 11-Sep-24 | Private Sale | 252,500 | $6.60 | $1,666,500.00 | (2%) 10.18M to 9.93M | |
| 13-Sep-24 6:56 PM View: | Schwab Andrew J. Director 10% Owner | Skye Bioscience, Inc. (SKYE) | 11-Sep-24 | Private Sale Duplicate | 252,500 | $6.60 | $1,666,500.00 | (2%) 10.18M to 9.93M | |
| 27-Aug-24 5:20 PM View: | Dhillon Punit Chief Executive Officer Director | Skye Bioscience, Inc. (SKYE) | 26-Aug-24 | Acquisition (other) | 15,727 | -- | -- | 4% 406.35K to 422.08K | |
| 15-Mar-24 4:15 PM View: | 5am Partners Vii, LLC 10% Owner | Skye Bioscience, Inc. (SKYE) | 13-Mar-24 | Purchase | 450,000 | $10.00 | $4,500,000.00 | 5% 9.73M to 10.18M | |
| 15-Mar-24 10:00 PM View: | Schwab Andrew J. Director 10% Owner | Skye Bioscience, Inc. (SKYE) | 13-Mar-24 | Grant | 450,000 | $10.00 | $4,500,000.00 | 5% 9.73M to 10.18M | |
| 04-Mar-24 7:53 PM View: | Grayson Paul A. Director | Skye Bioscience, Inc. (SKYE) | 29-Feb-24 | Grant | 100,000 | -- | -- | 41% 246.25K to 346.25K | |
| 04-Mar-24 6:19 AM View: | Diep Tuan Tu Chief Development Officer | Skye Bioscience, Inc. (SKYE) | 29-Feb-24 | Grant | 25,000 | -- | -- | 33% 76.83K to 101.83K | |
| 01-Mar-24 6:42 PM View: | Arsenault Kaitlyn Melanie Chief Financial Officer | Skye Bioscience, Inc. (SKYE) | 29-Feb-24 | Grant | 25,000 | -- | -- | 13% 185.74K to 210.74K | |
| 01-Mar-24 6:24 PM View: | Dhillon Punit Chief Executive Officer Director | Skye Bioscience, Inc. (SKYE) | 29-Feb-24 | Grant | 100,000 | -- | -- | 34% 297.01K to 397.01K | |
| 02-Feb-24 4:35 PM View: | Schwab Andrew J. Director 10% Owner | Skye Bioscience, Inc. (SKYE) | 31-Jan-24 | Grant | 5,206,070 | $2.31 | $12,026,000.00 | 115% 4.52M to 9.73M | |
| 02-Feb-24 4:32 PM View: | 5am Partners Vii, LLC 10% Owner | Skye Bioscience, Inc. (SKYE) | 31-Jan-24 | Purchase | 5,206,070 | $2.31 | $12,026,000.00 | 115% 4.52M to 9.73M | |
| 06-Nov-23 8:29 PM View: | Grayson Paul A. Director | Skye Bioscience, Inc. (SKYE) | 06-Nov-23 | Grant | 173,721 | -- | -- | 240% 72.53K to 246.25K | |
| 06-Nov-23 8:29 PM View: | Arsenault Kaitlyn Melanie Chief Financial Officer | Skye Bioscience, Inc. (SKYE) | 06-Nov-23 | Grant | 128,209 | -- | -- | 223% 57.53K to 185.74K | |
| 06-Nov-23 8:29 PM View: | Dhillon Punit Chief Executive Officer Director | Skye Bioscience, Inc. (SKYE) | 06-Nov-23 | Grant | 194,270 | -- | -- | 189% 102.74K to 297.01K | |
| 29-Aug-23 6:39 PM View: | Dhillon Punit Chief Executive Officer Director | Skye Bioscience, Inc. (SKYE) | 29-Aug-23 | Purchase | 881,000 | $0.02 | $16,474.70 | 2% 40.67M to 41.55M | |
| 29-Aug-23 6:39 PM View: | Dhillon Punit Chief Executive Officer Director | Skye Bioscience, Inc. (SKYE) | 28-Aug-23 | Acquisition (small) | 110,000 | $0.02 | $1,881.00 | < 1% 40.56M to 40.67M | |
| 29-Aug-23 7:25 PM View: | Grayson Paul A. Director | Skye Bioscience, Inc. (SKYE) | 25-Aug-23 | Grant | 18,132,600 | -- | -- | 100% 0 to 18.13M | |
| 29-Aug-23 6:53 PM View: | Arsenault Kaitlyn Melanie Chief Financial Officer | Skye Bioscience, Inc. (SKYE) | 25-Aug-23 | Grant | 13,382,100 | -- | -- | 1338% 1000.0K to 14.38M | |
| 29-Aug-23 6:39 PM View: | Dhillon Punit Chief Executive Officer Director | Skye Bioscience, Inc. (SKYE) | 25-Aug-23 | Grant | 20,277,400 | -- | -- | 100% 20.28M to 40.55M | |
| 29-Aug-23 6:39 PM View: | Dhillon Punit Chief Executive Officer Director | Skye Bioscience, Inc. (SKYE) | 23-Aug-23 | Acquisition (small) | 9,000 | $0.01 | $106.20 | < 1% 40.55M to 40.56M | |
| 22-Aug-23 5:21 PM View: | Schwab Andrew J. Director 10% Owner | Skye Bioscience, Inc. (SKYE) | 18-Aug-23 | Grant | 1,130,860,032 | $0.01 | $8,782,770.00 | 883482000% 0 to 1.13B | |
| 17-Mar-23 2:52 PM View: | Emerald Health Sciences Inc. 10% Owner | Skye Bioscience, Inc. (SKYE) | 22-Feb-23 | Grant | 58,020,600 | $0.03 | $1,880,140.00 | 52% 111.39M to 169.41M | |
| 15-Nov-22 12:24 PM View: | Rai Sukhwinder Singh Director | Skye Bioscience, Inc. (SKYE) | 10-Nov-22 | Grant | 95,718 | -- | -- | 100% 0 to 95.72K | |
| 15-Nov-22 1:41 PM View: | Dhillon Punit Chief Executive Officer Director | Skye Bioscience, Inc. (SKYE) | 10-Nov-22 | Grant | 1,406,540 | -- | -- | 47% 3.0M to 4.41M | |
| 15-Nov-22 1:41 PM View: | Dhillon Punit Chief Executive Officer Director | Skye Bioscience, Inc. (SKYE) | 10-Nov-22 | Grant | 2,335,720 | -- | -- | 53% 4.41M to 6.74M | |
| 16-Dec-21 6:59 PM View: | Arsenault Kaitlyn Melanie Chief Financial Officer | Skye Bioscience, Inc. (SKYE) | 14-Dec-21 | Grant | 1,000,000 | -- | -- | 100% 0 to 1000.0K | |
| 16-Dec-21 7:03 PM View: | Dhillon Punit Chief Executive Officer Director | Skye Bioscience, Inc. (SKYE) | 14-Dec-21 | Grant | 2,000,000 | -- | -- | 200% 1000.0K to 3.0M | |
| 11-Aug-20 2:53 PM View: | Dhillon Punit CEO Director | Skye Bioscience, Inc. (SKYE) | 07-Aug-20 | Purchase | 1,000,000 | $100,000.00 | $99,999,997,952.00 | 100% 0 to 1000.0K | |
| 11-Aug-20 3:15 PM View: | Emerald Health Sciences Inc. 10% Owner | Skye Bioscience, Inc. (SKYE) | 07-Aug-20 | Sale | 3,000,000 | $0.10 | $300,000.00 | (2%) 126.49M to 123.49M | |
| 11-Aug-20 2:52 PM View: | Heppell James L Director | Skye Bioscience, Inc. (SKYE) | 07-Aug-20 | Purchase | 500,000 | $50,000.00 | $24,999,999,488.00 | 100% 0 to 500.0K | |
| 31-Jan-22 10:00 PM View: | Emerald Health Sciences Inc. 10% Owner | Skye Bioscience, Inc. (SKYE) | 07-Aug-20 | Sale | 2,566,670 | $0.10 | $256,667.00 | (2%) 113.95M to 111.39M | |
| 28-Jan-20 4:31 PM View: | Emerald Health Sciences Inc. 10% Owner | Skye Bioscience, Inc. (SKYE) | 20-Dec-19 | Acquisition (other) | 40,800,000 | $4,080,000.00 | $166,464,006,914,048.00 | 48% 85.69M to 126.49M | |
| 28-Dec-18 6:59 PM View: | Emerald Health Sciences Inc. 10% Owner | Skye Bioscience, Inc. (SKYE) | 27-Dec-18 | Acquisition (other) | 37,667 | -- | -- | < 1% 73.12M to 73.15M | |
| 23-Jul-18 5:18 PM View: | Cesario Douglas A CFO and Secretary | Skye Bioscience, Inc. (SKYE) | 23-Jul-18 | Grant | 643,501 | -- | -- | 100% 0 to 643.5K | |
| 03-Apr-18 9:10 PM View: | Emerald Health Sciences Inc. 10% Owner | Skye Bioscience, Inc. (SKYE) | 29-Mar-18 | Conversion | 32,335,000 | $0.10 | $3,233,500.00 | 79% 40.78M to 73.12M | |
| 21-Feb-18 4:32 PM View: | Emerald Health Sciences Inc. 10% Owner | Skye Bioscience, Inc. (SKYE) | 16-Feb-18 | Purchase | 15,000,000 | -- | -- | 62% 24.0M to 39.0M | |
| 02-Mar-18 7:46 PM View: | Emerald Health Sciences Inc. 10% Owner | Skye Bioscience, Inc. (SKYE) | 24-Jan-18 | Exercise (in-the money or at-the-money) | 1,781,250 | $0.00 | $1,781.25 | 5% 39.0M to 40.78M | |
| 22-Jan-18 5:24 PM View: | Lykos Cosmas N Chairman Director 10% Owner | Skye Bioscience, Inc. (SKYE) | 18-Jan-18 | Grant | 900,000 | -- | -- | 24% 3.7M to 4.6M | |
| 22-Jan-18 5:24 PM View: | Murphy Brian Stuart CEO, Chief Medical Officer Director | Skye Bioscience, Inc. (SKYE) | 18-Jan-18 | Grant | 900,000 | -- | -- | 240% 375.0K to 1.27M | |
| 22-Jan-18 5:23 PM View: | Berecz Elizabeth Chief Financial Officer | Skye Bioscience, Inc. (SKYE) | 18-Jan-18 | Grant | 700,000 | -- | -- | 200% 350.0K to 1.05M | |
| 28-Mar-17 10:52 AM View: | Lapham Reg Alexander 10% Owner | Skye Bioscience, Inc. (SKYE) | 13-Mar-17 | Exercise (in-the money or at-the-money) | 119,700 | $1.00 | $119,700.00 | (3%) 3.91M to 3.79M | |
| 22-Oct-15 5:45 PM View: | George Thomas Director | Skye Bioscience, Inc. (SKYE) | 20-Oct-15 | Grant | 60,000 | -- | -- | 100% 0 to 60.0K | |
| 22-Oct-15 5:36 PM View: | Murphy Brian Stuart CEO, Chief Medical Officer Director | Skye Bioscience, Inc. (SKYE) | 20-Oct-15 | Grant | 375,000 | -- | -- | 100% 0 to 375.0K | |
| 22-Oct-15 5:39 PM View: | Berecz Elizabeth Chief Financial Officer | Skye Bioscience, Inc. (SKYE) | 20-Oct-15 | Grant | 350,000 | -- | -- | 100% 0 to 350.0K |
